Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | GPR3 | P46089 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.42 |
| ▸ | NQO2 | P16083 | 3/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31643056 | 0.85 | RAB9A (0.53) | RAB9ANPC1KMT2AMEN1HCRTR1 | |
| SCHEMBL20475325 | 0.85 | RAB9A (0.53) | RAB9ANPC1KMT2AMEN1HCRTR1 | |
| SCHEMBL183009 | 0.83 | NQO2 (0.57) | RAB9ANPC1KMT2AMEN1HCRTR1 | |
| Bromide SCHEMBL11421481 | 0.81 | NQO2 (0.55) | RAB9ANPC1KMT2AMEN1HCRTR1 | |
| SCHEMBL8048534 | 0.81 | CYP2A6 (0.52) | RAB9ANPC1KMT2AMEN1HCRTR1 | |
| SCHEMBL14015461 | 0.81 | CYP1A2 (0.50) | KMT2AMEN1MAPTGPR3CYP2A6 | |
| SCHEMBL1994979 | 0.78 | MAPT (0.50) | RAB9ANPC1KMT2AMEN1HCRTR1 | |
| SCHEMBL18805402 | 0.78 | MYC (0.52) | RAB9ANPC1KMT2AMEN1HCRTR1 | |
| SCHEMBL29581869 | 0.78 | MAPT (0.56) | RAB9ANPC1KMT2AHCRTR1MAPT | |
| SCHEMBL732274 | 0.78 | MAPT (0.56) | RAB9ANPC1KMT2AHCRTR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8529796-B2 | Charge transport compositions and electronic devices made with such compositions | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-10 | — | — | US | disclosed |
| US-20130009142-A1 | CHARGE TRANSPORT COMPOSITIONS AND ELECTRONIC DEVICES MADE WITH SUCH COMPOSITIONS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-10 | — | — | US | disclosed |
| US-8293139-B2 | Charge transport compositions and electronic devices made with such compositions | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-10-23 | — | — | US | disclosed |
| US-8287769-B2 | Charge transport compositions and electronic devices made with such compositions | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-10-16 | — | — | US | disclosed |
| US-20110140092-A1 | CHARGE TRANSPORT COMPOSITIONS AND ELECTRONIC DEVICES MADE WITH SUCH COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-06-16 | — | — | US | disclosed |
| US-20110133173-A1 | CHARGE TRANSPORT COMPOSITIONS AND ELECTRONIC DEVICES MADE WITH SUCH COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-06-09 | — | — | US | disclosed |
| US-7914706-B2 | Quinoxaline derivative; light-emitting diode, light-emitting electrochemical cell, photodetector, anti-quenching materials | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-03-29 | — | — | US | disclosed |
| US-20090242837-A1 | CHARGE TRANSPORT COMPOSITIONS AND ELECTRONIC DEVICES MADE WITH SUCH COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-10-01 | — | — | US | disclosed |
| US-20080227981-A1 | CHARGE TRANSPORT COMPOSITIONS AND ELECTRONIC DEVICES MADE WITH SUCH COMPOSITIONS | LG CHEM, LTD. (KR) | 2008-09-18 | — | — | US | disclosed |
| US-7265378-B2 | Electronic devices made with electron transport and/or anti-quenching layers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
| US-7265378-B2 | Electronic devices made with electron transport and/or anti-quenching layers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227981-A1 | CHARGE TRANSPORT COMPOSITIONS AND ELECTRONIC DEVICES MADE WITH SUCH COMPOSITIONS | SLC26A3, SLC6A19, SLC18A3 | RAB9A 1263/4885NPC1 518/4885KMT2A 2991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.